1. A systematic review of the research progress of traditional Chinese medicine against pulmonary fibrosis: from a pharmacological perspective
   Shanbo Qin et al, 2023, Chinese Medicine CrossRef
2. Astragaloside IV alleviates lung inflammation in Klebsiella pneumonia rats by suppressing TGF-β1/Smad pathway
   Lei Li et al, 2023, Brazilian Journal of Medical and Biological Research CrossRef
3. Astragaloside IV restrains pulmonary fibrosis progression via the circ_0008898/miR‐211‐5p/HMGB1 axis
   Min Zhu et al, 2024, Chemical Biology & Drug Design CrossRef
4. Yangqing Chenfei formula attenuates silica-induced pulmonary fibrosis by suppressing activation of fibroblast via regulating PI3K/AKT, JAK/STAT, and Wnt signaling pathway
   Fan Yang et al, 2023, Phytomedicine CrossRef
5. Astragalus and its formulas as a therapeutic option for fibrotic diseases: Pharmacology and mechanisms
   Yi Zhu et al, 2022, Frontiers in Pharmacology CrossRef
6. Therapeutic Effect of Astragali Radix Extract Injection Combined with Bone Marrow Mesenchymal Stem Cells in Bleomycin-Induced Pulmonary Fibrotic Rats
   Quanyu Du et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
7. Effect of Qiling Jiaogulan Powder on Pulmonary Fibrosis and Pulmonary Arteriole Remodeling in Low-Temperature-Exposed Broilers
   Juan Yu et al, 2022, Animals CrossRef
8. The state of astragaloside IV research: A bibliometric and visualized analysis
   Ning Liu et al, 2024, Fundamental & Clinical Pharmacology CrossRef
9. Traditional Chinese medicine inspired dual-drugs loaded inhalable nano-therapeutics alleviated idiopathic pulmonary fibrosis by targeting early inflammation and late fibrosis
   Meiling Zheng et al, 2024, Journal of Nanobiotechnology CrossRef
10. Chinese medicinal plant Polygonum cuspidatum ameliorates silicosis via suppressing the Wnt/β-catenin pathway
    Yangmin Jia et al, 2022, Open Chemistry CrossRef
11. Linking NLRP3 inflammasome and pulmonary fibrosis: mechanistic insights and promising therapeutic avenues
    Shobhit Gairola et al, 2024, Inflammopharmacology CrossRef
12. Geniposide improves bleomycin-induced pulmonary fibrosis by inhibiting NLRP3 inflammasome activation and modulating metabolism
    Yi Wei et al, 2023, Journal of Functional Foods CrossRef
13. Astragaloside IV alleviates sepsis-induced muscle atrophy by inhibiting the TGF-β1/Smad signaling pathway
    Hongkai Dai et al, 2023, International Immunopharmacology CrossRef
14. Alpha‐Lipoic Acid Modulates the Oxidative and Inflammatory Responses Induced by Traditional and Novel Tobacco Products in Human Liver Epithelial Cells
    Rengin Reis et al, 2023, Chemistry & Biodiversity CrossRef
15. Astragaloside IV inhibits epithelial-mesenchymal transition and pulmonary fibrosis via lncRNA-ATB/miR-200c/ZEB1 signaling pathway
    Yanyun Guan et al, 2024, Gene CrossRef
16. Herbal Compounds in the Treatment of Pulmonary Silicosis
    J ADAMCAKOVA et al, 2021, Physiological Research CrossRef
17. Research progress on the antitumor effects of astragaloside IV
    Ruixi Zhou et al, 2023, European Journal of Pharmacology CrossRef
18. Herbal Compounds in the Treatment of Pulmonary Silicosis
    J ADAMCAKOVA et al, 2021, Physiological Research CrossRef